Bank Makramah Rs10bn Injection Signals a Bigger Bet
Bank Makramah's sponsor just agreed to put in another Rs10 billion — his third direct cash injection since 2023. On its own, that's a capital top-up; set against his full history with the bank, it looks more like a pattern worth understanding.
Bank Makramah Rs10bn is the number making the rounds this week, but it's really the third capital injection from the same sponsor in three years — and that repetition matters more than the headline figure itself.
Bank Makramah Limited's (PSX: BML) Board approved the deal at its 159th meeting on August 18, 2026, authorizing the President/CEO to sign an agreement with the sponsor for the deposit. It's the same funding mechanism BML has used twice before — cash in now, formal shares later.
Key Takeaways
- BML's Board approved a new Rs10bn sponsor deposit on August 18, 2026, its 159th board meeting.
- The cash is recorded as an advance against future share subscription, pending regulatory approval for share issuance outside a rights issue.
- It's the sponsor's third direct injection since 2023: Rs10bn (2023), Rs5bn (2025), and now Rs10bn (2026) — Rs25bn in direct cash.
- The sponsor, Nasser Abdulla Hussain Lootah, held roughly 75.8% of BML after a January 2026 restructuring.
- The injection follows BML's return to profit in CY25 (Rs8.83bn, after a Rs5.21bn loss in CY24).
- It also follows DM Holdings' June 2026 acquisition-intent filing for a stake in BML — a separate development with no confirmed connection to this injection.
What Is the New Bank Makramah Rs10bn Investment?
Per Mettis Global's report of the bank's PSX filing, BML's Board approved an investment proposal at its 159th meeting on August 18, 2026, authorizing the President/CEO to execute an agreement with the sponsor.
Under that agreement, the sponsor deposits Rs10 billion into the bank, recorded as an advance against share subscription — not an immediate share issuance. Formal shares follow once regulatory and corporate approvals are secured for a route other than a standard rights issue.
Why Bank Makramah Rs10bn Keeps Coming From the Same Sponsor
Nasser Abdulla Hussain Lootah is the sponsor behind this — a UAE-based businessman who became BML's majority shareholder back in April 2023 with an initial Rs10bn injection, 3.98 billion new shares at Rs2.51 apiece.
That single deal reshaped the bank: Summit Bank was renamed Bank Makramah Limited later that year, with a stated goal of transitioning it into a fully Islamic bank. Every capital move since has built on that original commitment, not replaced it.
How the Bank Makramah Rs10bn Deal Actually Works
Bank Makramah Rs10bn: The Sponsor's Capital Injection Timeline
The "advance against share subscription" structure isn't new for BML — it's the same mechanism used for the sponsor's 2025 top-up, and the same regulatory logic applies each time: getting cash into the bank fast, while the paperwork for actual share issuance catches up.
| Date | Amount | What happened |
|---|---|---|
| April 2023 | Rs10bn | 3.98bn new shares @ Rs2.51; sponsor becomes majority shareholder |
| July 2025 | Rs5bn | Advance against share subscription |
| November 2025 | Rs41bn total | Cumulative commitment incl. GHDL merger effect; BML reaches SBP's minimum capital requirement |
| August 2026 | Rs10bn | New advance against share subscription (this announcement) |
Why the roundabout structure? Issuing new shares outside a standard rights issue needs separate SBP and corporate approvals, which take time. Recording the cash as an advance lets BML use the capital immediately rather than waiting on that process to formally allot shares.
What Bank Makramah Rs10bn Means Next to the DM Holdings Bid
Here's the part worth noting without over-reading it: in June 2026, a consortium led by DM Holdings Limited submitted formal acquisition intent for a stake in BML, a move that could trigger a mandatory public offer for at least half the bank's remaining shares.
Two months later, the founding sponsor is putting in more capital of his own. Nothing on record ties the two events together, and reading a defensive motive into the timing would be speculation — but a sponsor deepening his commitment while an outside buyer is circling is, at minimum, a detail worth watching rather than skipping past.
Bank Makramah Rs10bn in the Context of BML's Turnaround
Bank Makramah Rs10bn Arrives After a Profit Turnaround
The timing lines up with a genuine improvement in BML's fundamentals. The bank swung to a Rs8.83bn net profit for CY25, a sharp reversal from a Rs5.21bn net loss the year before, with EPS recovering to Rs8.83 from a loss per share of Rs1.
Add in the January 2026 restructuring, which cut the sponsor's stake from 86.1% to roughly 75.8% in minority shareholders' favour, and this new Rs10bn starts to look less like a rescue and more like growth capital — the "next stage" the sponsor has talked about since 2023.
What to Watch After the Bank Makramah Rs10bn Announcement
- Whether and when the sponsor's cash actually converts into formally issued shares.
- How DM Holdings' acquisition-intent process develops from here.
- Whether BML's improving profitability supports a return to dividend payouts, as hinted in January 2026.
- The sponsor's total stake trajectory once this deposit is eventually converted to shares.
Bank Makramah's Sponsor Commitment at a Glance
Bank Makramah Rs10bn FAQs
What is the new Bank Makramah Rs10bn investment?
On August 18, 2026, BML's Board approved an agreement for its sponsor to deposit Rs10 billion, recorded as an advance against future share subscription pending regulatory approvals.
Who is Bank Makramah's sponsor?
Nasser Abdulla Hussain Lootah, a UAE-based businessman who became BML's majority shareholder in 2023 and held roughly 75.8% of the bank following a January 2026 restructuring.
Why does BML keep getting advances instead of issuing shares directly?
Share issuance outside a rights issue needs separate regulatory and corporate approvals. Recording the sponsor's cash as an advance lets the bank use the capital immediately while that process runs.
How much has BML's sponsor invested in total?
This is his third direct cash injection since 2023 — Rs10bn, then Rs5bn, now a further Rs10bn — totaling Rs25bn in direct deposits, on top of a broader Rs41bn commitment reported as of November 2025 that also reflected the GHDL merger.
Sources & Last Verified
- August 18, 2026 Rs10bn investment approval
- Mettis Global's report of Bank Makramah's PSX regulatory notification, published August 18, 2026. No second independent outlet had covered this story at the time of writing — flagged here for transparency rather than presented as broadly corroborated.
- 2023-2025 sponsor injection history, restructuring, CY25 results, DM Holdings bid
- Cross-checked across Dawn, Business Recorder, Profit by Pakistan Today, Mettis Global and Bank Makramah's own website.
- Analysis connecting the injection pattern, the DM Holdings bid, and BML's turnaround
- PakFinHub analysis.
- Last verified
- August 20, 2026. This article is informational only and isn't investment advice.
Strip away the paperwork and Bank Makramah Rs10bn is really the latest chapter in a three-year-old commitment, not a new story on its own. Whether it's simply growth capital or something shaped by DM Holdings' interest in the background is the part nobody's confirmed yet — worth watching for whichever comes first, the share issuance or DM Holdings' next move.
Where Bank Makramah Goes From Here
A sponsor doubling down and an outside bidder circling make for two storylines worth tracking together, not separately.